• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
MRC Laboratory of Molecular Biology

MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

  • Home
  • About LMB
  • Research
  • Research Groups
  • Students
  • Recruitment
  • Life at the LMB
  • Achievements
  • News & Events
Home > LMB In The News > A new line of research in the fight against Alzheimer’s disease and dementia

A new line of research in the fight against Alzheimer’s disease and dementia

Published on 15 February, 2010

“Etienne-Emile Baulieu’s research team (Inserm research unit 788 “Steroids, neuroprotection et neuroregeneration”), in collaboration with Michel Goedert (who originally characterised the Tau protein in Alzheimer’s disease in 1998) have just identified an interaction between the dysfunctional Tau protein and another protein, FKBP52. Using tools from biochemistry and molecular biology, the researchers established that there was a specific physical link between these two proteins in the brain. They demonstrated in vitro that the FKBP52 protein suppressed activity of the Tau protein, and hence prevented its role in the assembly of microtubules, known for their role in transporting nutrient and information-bearing molecules into the cell…” More…

Primary Sidebar

Search

  • Privacy & Cookies
  • Contact Directory
  • Freedom of Information
  • Site Map
Find Us
©2023 MRC Laboratory of Molecular Biology,
Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK. 01223 267000

The MRC is part of UK Research and Innovation

Contact Us